drugset / Trial / NCT00256854
Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
RandomizedParallel-groupTreatment
Summary
This is a multi-center, Phase III study to evaluate the safety and tolerability of proposed dose conversion recommendations for RLS subjects converting from ropinirole immediate release to ropinirole controlled-release for RLS.
Timeline
- Start
- 2005-11-14
- Primary completion
- 2006-09-21
- Completion
- 2006-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropinirole | Small molecule | 1 mg | — |
| Subject | Ropinirole | Small molecule | 2 mg | — |
| Subject | Ropinirole | Small molecule | 3 mg | — |